Browsing CEMCAT - Articles científics by Subject "Anticossos monoclonals - Ús terapèutic"
Now showing items 1-5 of 5
-
Consensus statement on the use of alemtuzumab in daily clinical practice in Spain
(Elsevier, 2022-10) -
Vaccine Safety and Immunogenicity in Patients With Multiple Sclerosis Treated With Natalizumab
(American Medical Association, 2024-04-01)